advances in car-t therapy for r/r multiple myeloma: ide-cel & cilta-cel
Published 2 years ago • 414 plays • Length 5:56Download video MP4
Download video MP3
Similar videos
-
2:00
the value of car-t cell therapy for the treatment of r/r multiple myeloma
-
3:03
the future of car-t therapy for multiple myeloma
-
1:01
the potentially curative role of car-t therapy in myeloma
-
1:15
ide-cel car t-cell therapy for r/r myeloma in karmma-3
-
2:35
latest advances in car-t for multiple myeloma: cilta-cel & new car-t platforms
-
4:47
phase i study of bb21217 car-t therapy in r/r myeloma
-
1:15
the current status and future of car-t therapy in r/r myeloma
-
1:12
optimizing car-t therapy for patients with multiple myeloma in the real-world
-
9:58
the management & optimization of car t-cell therapy in myeloma
-
2:12
multiple myeloma: elranatamab as a single-agent therapy compared to car-t therapy
-
1:45
evaluating nivolumab-based therapy to restore t-cell fitness in patients with r/r multiple myeloma
-
1:33
ide-cel car t-cell therapy in newly diagnosed high-risk myeloma
-
2:23
improving car t-cell therapy for myeloma
-
3:27
car-t cells in myeloma
-
3:23
bringing car-t therapy in earlier lines of treatment in myeloma: karmma-3, cartitude-4 & cartitude-6
-
1:38
real world use of car t-cell therapy in multiple myeloma
-
0:47
novel targets in car-t therapy for multiple myeloma: integrin beta-7 & cd98 heavy chain
-
9:48
the use of car t-cells in multiple myeloma
-
3:44
clinical advances with car-ts and bispecifics in r/r myeloma